NanoViricides Inc. (NNVC)

[jg35]

I am well aware that Fluicide works in the blood and does not need to enter cells to work. That doesn't mean it can't have side effects in humans not seen in rats. Nor does it guarantee that it will work in humans.

I am happy that Diwan has confidence in his company. I hope he's right. But I also know that the top executives of a company sometimes have an over optimistic view of their company's prospects. Excessive optimism is almost a requirement for an entrepreneur. (Few of them would start a business if they realized just how miserable the odds really are.)

If Fluicide is ever to be sold in the U.S. it will indeed be necessary to deal with the capriciousness of the FDA. If the clinical trials in Australia unequivocally show safety and clear indication of efficacy then that's great for NNVC. But if the results fail or are merely ambiguous that will be a major blow to NNVC, easily adding another year or more of delay. So yes, it is possible for a company like NNVC to run out of money, and not terribly unlikely unless everything works out just as you hope it does.